Steven Gans

3.0k total citations
20 papers, 941 citations indexed

About

Steven Gans is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Steven Gans has authored 20 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Steven Gans's work include Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Steven Gans is often cited by papers focused on Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Steven Gans collaborates with scholars based in Netherlands, United States and Belgium. Steven Gans's co-authors include Bonne Biesma, Stephan Stenglein, Sergio Harari, J. Thirlwell, Péter Kardos, Claus Vogelmeier, Giuseppe Giaccone, C. Debruyne, Jan P. van Meerbeeck and Catherine Legrand and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

Steven Gans

20 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Gans Netherlands 12 638 481 190 155 108 20 941
Hubert de Crémoux France 19 806 1.3× 410 0.9× 168 0.9× 176 1.1× 204 1.9× 48 1.2k
Takayuki Shiroyama Japan 19 826 1.3× 858 1.8× 133 0.7× 124 0.8× 137 1.3× 112 1.4k
F. Vaylet France 12 618 1.0× 466 1.0× 133 0.7× 57 0.4× 66 0.6× 96 848
P C Hoffman United States 16 570 0.9× 552 1.1× 146 0.8× 22 0.1× 201 1.9× 46 975
Hirohiko Akiyama Japan 20 556 0.9× 311 0.6× 230 1.2× 20 0.1× 87 0.8× 75 1.0k
Tetsuhiko Taira Japan 20 636 1.0× 589 1.2× 188 1.0× 126 0.8× 126 1.2× 58 1.1k
Isabelle Monnet France 14 840 1.3× 666 1.4× 144 0.8× 56 0.4× 343 3.2× 36 1.1k
Ryuichi Kubo Japan 16 226 0.4× 551 1.1× 113 0.6× 75 0.5× 41 0.4× 41 861
Francisco A. Almeida United States 17 664 1.0× 151 0.3× 102 0.5× 84 0.5× 38 0.4× 59 853
Padmini Giri United States 6 590 0.9× 911 1.9× 195 1.0× 19 0.1× 148 1.4× 11 1.9k

Countries citing papers authored by Steven Gans

Since Specialization
Citations

This map shows the geographic impact of Steven Gans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Gans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Gans more than expected).

Fields of papers citing papers by Steven Gans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Gans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Gans. The network helps show where Steven Gans may publish in the future.

Co-authorship network of co-authors of Steven Gans

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Gans. A scholar is included among the top collaborators of Steven Gans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Gans. Steven Gans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahn, Myung‐Ju, Igor Bondarenko, Ewa Kalinka‐Warzocha, et al.. (2023). Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION Study. Journal of Thoracic Oncology. 18(11). 1594–1606. 8 indexed citations
2.
Byers, Lauren A., Dmitry Bentsion, Steven Gans, et al.. (2021). Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study. Clinical Cancer Research. 27(14). 3884–3895. 52 indexed citations
3.
4.
Seyedmousavi, Seyedmojtaba, Steven Gans, Willem J. G. Melchers, et al.. (2017). Successful treatment of azole-resistant invasive aspergillosis in a bottlenose dolphin with high-dose posaconazole. Medical Mycology Case Reports. 16. 16–19. 17 indexed citations
5.
McGee, L.A., J. Chang, Vinai Gondi, et al.. (2017). Postmastectomy Chest Wall Reirradiation With Proton Therapy for Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(2). E34–E35. 5 indexed citations
6.
Buikhuisen, Wieneke A., Jacobus A. Burgers, Andrew Vincent, et al.. (2013). Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study. The Lancet Oncology. 14(6). 543–551. 57 indexed citations
7.
Paz‐Ares, Luis, Bonne Biesma, David F. Heigener, et al.. (2012). Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 30(25). 3084–3092. 198 indexed citations
8.
Richardson, Gary, Tudor–Eliade Ciuleanu, Luís Costa, et al.. (2011). Denosumab versus zoledronic acid in patients with bone metastases from solid tumors other than breast and prostate cancers or multiple myeloma: A number needed to treat (NNT) analysis.. Journal of Clinical Oncology. 29(15_suppl). 9115–9115. 2 indexed citations
9.
Scagliotti, Giorgio V., Keunchil Park, Shekar Patil, et al.. (2009). Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study. European Journal of Cancer. 45(13). 2298–2303. 32 indexed citations
10.
Scagliotti, Giorgio V., Paul Germonpré, Leon Bosquée, et al.. (2009). A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer. Lung Cancer. 68(3). 420–426. 48 indexed citations
11.
Vogelmeier, Claus, Péter Kardos, Sergio Harari, et al.. (2008). Formoterol mono- and combination therapy with tiotropium in patients with COPD: A 6-month study. Respiratory Medicine. 102(11). 1511–1520. 140 indexed citations
12.
Scagliotti, Giorgio V., Shekhar Patil, Janusz Rolski, et al.. (2007). 6519 ORAL Favorable benefit to risk profile for pemetrexed plus cisplatin versus gemcitabine plus cisplatin in a large phase III study of first-line therapy in advanced non-small cell lung cancer. European Journal of Cancer Supplements. 5(4). 363–363. 2 indexed citations
13.
Gans, Steven, et al.. (2004). Hypofractionated external beam radiotherapy as retreatment for symptomatic non–small-cell lung carcinoma: an effective treatment?. International Journal of Radiation Oncology*Biology*Physics. 58(5). 1388–1393. 45 indexed citations
14.
Ardizzoni, Andrea, Vivianne C. G. Tjan‐Heijnen, Pieter E. Postmus, et al.. (2002). Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer: A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923. Journal of Clinical Oncology. 20(19). 3947–3955. 75 indexed citations
15.
Tjan‐Heijnen, Vivianne C. G., Pieter E. Postmus, Andrea Ardizzoni, et al.. (2001). Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study. Annals of Oncology. 12(10). 1359–1368. 79 indexed citations
16.
17.
Gans, Steven, et al.. (2001). Pulmonary function measurements in dolphins using capnography. Veterinary Record. 149(10). 308–309. 6 indexed citations
18.
19.
20.
Gans, Steven, et al.. (1988). Pulmonary hyalinizing granuloma. European Respiratory Journal. 1(4). 389–391. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hubert de Crémoux Breakdown of academic impact, for papers by Takayuki Shiroyama Breakdown of academic impact, for papers by F. Vaylet Breakdown of academic impact, for papers by P C Hoffman Breakdown of academic impact, for papers by Hirohiko Akiyama Breakdown of academic impact, for papers by Tetsuhiko Taira Breakdown of academic impact, for papers by Isabelle Monnet Breakdown of academic impact, for papers by Ryuichi Kubo Breakdown of academic impact, for papers by Francisco A. Almeida Breakdown of academic impact, for papers by Padmini Giri
Rankless by CCL
2026